Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Tenet’s $1.2 Billion Acquisition of SurgCenter Development
Willkie Farr & Gallagher advised Tenet Healthcare Corporation and its subsidiary United Surgical Partners International (USPI) in the transaction. Tenet Healthcare Corporation (NYSE: THC) entered into a...